Seroprevalence of Chronic Hepatitis B Virus Infection and Prior Immunity in Immigrants and Refugees: A Systematic Review and Meta-Analysis
International migrants experience increased mortality from hepatocellular carcinoma compared to host populations, largely due to undetected chronic hepatitis B infection (HBV). We conducted a systematic review of the seroprevalence of chronic HBV and prior immunity in migrants arriving in low HBV pr...
Saved in:
| Published in | PloS one Vol. 7; no. 9; p. e44611 |
|---|---|
| Main Authors | , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Public Library of Science
05.09.2012
Public Library of Science (PLoS) |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | International migrants experience increased mortality from hepatocellular carcinoma compared to host populations, largely due to undetected chronic hepatitis B infection (HBV). We conducted a systematic review of the seroprevalence of chronic HBV and prior immunity in migrants arriving in low HBV prevalence countries to identify those at highest risk in order to guide disease prevention and control strategies.
Medline, Medline In-Process, EMBASE and the Cochrane Database of Systematic Reviews were searched. Studies that reported HBV surface antigen or surface antibodies in migrants were included. The seroprevalence of chronic HBV and prior immunity were pooled by region of origin and immigrant class, using a random-effects model. A random-effects logistic regression was performed to explore heterogeneity. The number of chronically infected migrants in each immigrant-receiving country was estimated using the pooled HBV seroprevalences and country-specific census data. A total of 110 studies, representing 209,822 immigrants and refugees were included. The overall pooled seroprevalence of infection was 7.2% (95% CI: 6.3%-8.2%) and the seroprevalence of prior immunity was 39.7% (95% CI: 35.7%-43.9%). HBV seroprevalence differed significantly by region of origin. Migrants from East Asia and Sub-Saharan Africa were at highest risk and migrants from Eastern Europe were at an intermediate risk of infection. Region of origin, refugee status and decade of study were independently associated with infection in the adjusted random-effects logistic model. Almost 3.5 million migrants (95% CI: 2.8-4.5 million) are estimated to be chronically infected with HBV.
The seroprevalence of chronic HBV infection is high in migrants from most world regions, particularly among those from East Asia, Sub-Saharan Africa and Eastern Europe, and more than 50% were found to be susceptible to HBV. Targeted screening and vaccination of international migrants can become an important component of HBV disease control efforts in immigrant-receiving countries. |
|---|---|
| AbstractList | International migrants experience increased mortality from hepatocellular carcinoma compared to host populations, largely due to undetected chronic hepatitis B infection (HBV). We conducted a systematic review of the seroprevalence of chronic HBV and prior immunity in migrants arriving in low HBV prevalence countries to identify those at highest risk in order to guide disease prevention and control strategies. Medline, Medline In-Process, EMBASE and the Cochrane Database of Systematic Reviews were searched. Studies that reported HBV surface antigen or surface antibodies in migrants were included. The seroprevalence of chronic HBV and prior immunity were pooled by region of origin and immigrant class, using a random-effects model. A random-effects logistic regression was performed to explore heterogeneity. The number of chronically infected migrants in each immigrant-receiving country was estimated using the pooled HBV seroprevalences and country-specific census data. A total of 110 studies, representing 209,822 immigrants and refugees were included. The overall pooled seroprevalence of infection was 7.2% (95% CI: 6.3%-8.2%) and the seroprevalence of prior immunity was 39.7% (95% CI: 35.7%-43.9%). HBV seroprevalence differed significantly by region of origin. Migrants from East Asia and Sub-Saharan Africa were at highest risk and migrants from Eastern Europe were at an intermediate risk of infection. Region of origin, refugee status and decade of study were independently associated with infection in the adjusted random-effects logistic model. Almost 3.5 million migrants (95% CI: 2.8-4.5 million) are estimated to be chronically infected with HBV. The seroprevalence of chronic HBV infection is high in migrants from most world regions, particularly among those from East Asia, Sub-Saharan Africa and Eastern Europe, and more than 50% were found to be susceptible to HBV. Targeted screening and vaccination of international migrants can become an important component of HBV disease control efforts in immigrant-receiving countries. International migrants experience increased mortality from hepatocellular carcinoma compared to host populations, largely due to undetected chronic hepatitis B infection (HBV). We conducted a systematic review of the seroprevalence of chronic HBV and prior immunity in migrants arriving in low HBV prevalence countries to identify those at highest risk in order to guide disease prevention and control strategies. Medline, Medline In-Process, EMBASE and the Cochrane Database of Systematic Reviews were searched. Studies that reported HBV surface antigen or surface antibodies in migrants were included. The seroprevalence of chronic HBV and prior immunity were pooled by region of origin and immigrant class, using a random-effects model. A random-effects logistic regression was performed to explore heterogeneity. The number of chronically infected migrants in each immigrant-receiving country was estimated using the pooled HBV seroprevalences and country-specific census data. A total of 110 studies, representing 209,822 immigrants and refugees were included. The overall pooled seroprevalence of infection was 7.2% (95% CI: 6.3%-8.2%) and the seroprevalence of prior immunity was 39.7% (95% CI: 35.7%-43.9%). HBV seroprevalence differed significantly by region of origin. Migrants from East Asia and Sub-Saharan Africa were at highest risk and migrants from Eastern Europe were at an intermediate risk of infection. Region of origin, refugee status and decade of study were independently associated with infection in the adjusted random-effects logistic model. Almost 3.5 million migrants (95% CI: 2.8-4.5 million) are estimated to be chronically infected with HBV. The seroprevalence of chronic HBV infection is high in migrants from most world regions, particularly among those from East Asia, Sub-Saharan Africa and Eastern Europe, and more than 50% were found to be susceptible to HBV. Targeted screening and vaccination of international migrants can become an important component of HBV disease control efforts in immigrant-receiving countries. Background International migrants experience increased mortality from hepatocellular carcinoma compared to host populations, largely due to undetected chronic hepatitis B infection (HBV). We conducted a systematic review of the seroprevalence of chronic HBV and prior immunity in migrants arriving in low HBV prevalence countries to identify those at highest risk in order to guide disease prevention and control strategies. Methods and Findings Medline, Medline In-Process, EMBASE and the Cochrane Database of Systematic Reviews were searched. Studies that reported HBV surface antigen or surface antibodies in migrants were included. The seroprevalence of chronic HBV and prior immunity were pooled by region of origin and immigrant class, using a random-effects model. A random-effects logistic regression was performed to explore heterogeneity. The number of chronically infected migrants in each immigrant-receiving country was estimated using the pooled HBV seroprevalences and country-specific census data. A total of 110 studies, representing 209,822 immigrants and refugees were included. The overall pooled seroprevalence of infection was 7.2% (95% CI: 6.3%-8.2%) and the seroprevalence of prior immunity was 39.7% (95% CI: 35.7%-43.9%). HBV seroprevalence differed significantly by region of origin. Migrants from East Asia and Sub-Saharan Africa were at highest risk and migrants from Eastern Europe were at an intermediate risk of infection. Region of origin, refugee status and decade of study were independently associated with infection in the adjusted random-effects logistic model. Almost 3.5 million migrants (95% CI: 2.8-4.5 million) are estimated to be chronically infected with HBV. Conclusions The seroprevalence of chronic HBV infection is high in migrants from most world regions, particularly among those from East Asia, Sub-Saharan Africa and Eastern Europe, and more than 50% were found to be susceptible to HBV. Targeted screening and vaccination of international migrants can become an important component of HBV disease control efforts in immigrant-receiving countries. International migrants experience increased mortality from hepatocellular carcinoma compared to host populations, largely due to undetected chronic hepatitis B infection (HBV). We conducted a systematic review of the seroprevalence of chronic HBV and prior immunity in migrants arriving in low HBV prevalence countries to identify those at highest risk in order to guide disease prevention and control strategies.BACKGROUNDInternational migrants experience increased mortality from hepatocellular carcinoma compared to host populations, largely due to undetected chronic hepatitis B infection (HBV). We conducted a systematic review of the seroprevalence of chronic HBV and prior immunity in migrants arriving in low HBV prevalence countries to identify those at highest risk in order to guide disease prevention and control strategies.Medline, Medline In-Process, EMBASE and the Cochrane Database of Systematic Reviews were searched. Studies that reported HBV surface antigen or surface antibodies in migrants were included. The seroprevalence of chronic HBV and prior immunity were pooled by region of origin and immigrant class, using a random-effects model. A random-effects logistic regression was performed to explore heterogeneity. The number of chronically infected migrants in each immigrant-receiving country was estimated using the pooled HBV seroprevalences and country-specific census data. A total of 110 studies, representing 209,822 immigrants and refugees were included. The overall pooled seroprevalence of infection was 7.2% (95% CI: 6.3%-8.2%) and the seroprevalence of prior immunity was 39.7% (95% CI: 35.7%-43.9%). HBV seroprevalence differed significantly by region of origin. Migrants from East Asia and Sub-Saharan Africa were at highest risk and migrants from Eastern Europe were at an intermediate risk of infection. Region of origin, refugee status and decade of study were independently associated with infection in the adjusted random-effects logistic model. Almost 3.5 million migrants (95% CI: 2.8-4.5 million) are estimated to be chronically infected with HBV.METHODS AND FINDINGSMedline, Medline In-Process, EMBASE and the Cochrane Database of Systematic Reviews were searched. Studies that reported HBV surface antigen or surface antibodies in migrants were included. The seroprevalence of chronic HBV and prior immunity were pooled by region of origin and immigrant class, using a random-effects model. A random-effects logistic regression was performed to explore heterogeneity. The number of chronically infected migrants in each immigrant-receiving country was estimated using the pooled HBV seroprevalences and country-specific census data. A total of 110 studies, representing 209,822 immigrants and refugees were included. The overall pooled seroprevalence of infection was 7.2% (95% CI: 6.3%-8.2%) and the seroprevalence of prior immunity was 39.7% (95% CI: 35.7%-43.9%). HBV seroprevalence differed significantly by region of origin. Migrants from East Asia and Sub-Saharan Africa were at highest risk and migrants from Eastern Europe were at an intermediate risk of infection. Region of origin, refugee status and decade of study were independently associated with infection in the adjusted random-effects logistic model. Almost 3.5 million migrants (95% CI: 2.8-4.5 million) are estimated to be chronically infected with HBV.The seroprevalence of chronic HBV infection is high in migrants from most world regions, particularly among those from East Asia, Sub-Saharan Africa and Eastern Europe, and more than 50% were found to be susceptible to HBV. Targeted screening and vaccination of international migrants can become an important component of HBV disease control efforts in immigrant-receiving countries.CONCLUSIONSThe seroprevalence of chronic HBV infection is high in migrants from most world regions, particularly among those from East Asia, Sub-Saharan Africa and Eastern Europe, and more than 50% were found to be susceptible to HBV. Targeted screening and vaccination of international migrants can become an important component of HBV disease control efforts in immigrant-receiving countries. Background International migrants experience increased mortality from hepatocellular carcinoma compared to host populations, largely due to undetected chronic hepatitis B infection (HBV). We conducted a systematic review of the seroprevalence of chronic HBV and prior immunity in migrants arriving in low HBV prevalence countries to identify those at highest risk in order to guide disease prevention and control strategies. Methods and Findings Medline, Medline In-Process, EMBASE and the Cochrane Database of Systematic Reviews were searched. Studies that reported HBV surface antigen or surface antibodies in migrants were included. The seroprevalence of chronic HBV and prior immunity were pooled by region of origin and immigrant class, using a random-effects model. A random-effects logistic regression was performed to explore heterogeneity. The number of chronically infected migrants in each immigrant-receiving country was estimated using the pooled HBV seroprevalences and country-specific census data. A total of 110 studies, representing 209,822 immigrants and refugees were included. The overall pooled seroprevalence of infection was 7.2% (95% CI: 6.3%–8.2%) and the seroprevalence of prior immunity was 39.7% (95% CI: 35.7%–43.9%). HBV seroprevalence differed significantly by region of origin. Migrants from East Asia and Sub-Saharan Africa were at highest risk and migrants from Eastern Europe were at an intermediate risk of infection. Region of origin, refugee status and decade of study were independently associated with infection in the adjusted random-effects logistic model. Almost 3.5 million migrants (95% CI: 2.8–4.5 million) are estimated to be chronically infected with HBV. Conclusions The seroprevalence of chronic HBV infection is high in migrants from most world regions, particularly among those from East Asia, Sub-Saharan Africa and Eastern Europe, and more than 50% were found to be susceptible to HBV. Targeted screening and vaccination of international migrants can become an important component of HBV disease control efforts in immigrant-receiving countries. BackgroundInternational migrants experience increased mortality from hepatocellular carcinoma compared to host populations, largely due to undetected chronic hepatitis B infection (HBV). We conducted a systematic review of the seroprevalence of chronic HBV and prior immunity in migrants arriving in low HBV prevalence countries to identify those at highest risk in order to guide disease prevention and control strategies.Methods and findingsMedline, Medline In-Process, EMBASE and the Cochrane Database of Systematic Reviews were searched. Studies that reported HBV surface antigen or surface antibodies in migrants were included. The seroprevalence of chronic HBV and prior immunity were pooled by region of origin and immigrant class, using a random-effects model. A random-effects logistic regression was performed to explore heterogeneity. The number of chronically infected migrants in each immigrant-receiving country was estimated using the pooled HBV seroprevalences and country-specific census data. A total of 110 studies, representing 209,822 immigrants and refugees were included. The overall pooled seroprevalence of infection was 7.2% (95% CI: 6.3%-8.2%) and the seroprevalence of prior immunity was 39.7% (95% CI: 35.7%-43.9%). HBV seroprevalence differed significantly by region of origin. Migrants from East Asia and Sub-Saharan Africa were at highest risk and migrants from Eastern Europe were at an intermediate risk of infection. Region of origin, refugee status and decade of study were independently associated with infection in the adjusted random-effects logistic model. Almost 3.5 million migrants (95% CI: 2.8-4.5 million) are estimated to be chronically infected with HBV.ConclusionsThe seroprevalence of chronic HBV infection is high in migrants from most world regions, particularly among those from East Asia, Sub-Saharan Africa and Eastern Europe, and more than 50% were found to be susceptible to HBV. Targeted screening and vaccination of international migrants can become an important component of HBV disease control efforts in immigrant-receiving countries. |
| Audience | Academic |
| Author | Shrier, Ian Klein, Marina B. Cnossen, Sonya Greenaway, Chris Schwartzman, Kevin Rossi, Carmine Schwarzer, Guido Marshall, Lee |
| AuthorAffiliation | 3 Respiratory Epidemiology and Clinical Research Unit, Montreal Chest Institute, McGill University, Montreal, Canada 1 Centre for Clinical Epidemiology and Community Studies of the Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Canada Centers for Disease Control and Prevention, United States of America 6 Division of Infectious Diseases, Jewish General Hospital, McGill University, Montreal, Canada 5 Institute of Medical Biometry and Medical Informatics, University of Freiburg, Freiburg, Germany 2 Department of Epidemiology, Biostatistics & Occupational Health, McGill University, Montreal, Canada 4 Division of Infectious Diseases, McGill University Health Centre, McGill University, Montreal, Canada |
| AuthorAffiliation_xml | – name: 4 Division of Infectious Diseases, McGill University Health Centre, McGill University, Montreal, Canada – name: Centers for Disease Control and Prevention, United States of America – name: 3 Respiratory Epidemiology and Clinical Research Unit, Montreal Chest Institute, McGill University, Montreal, Canada – name: 2 Department of Epidemiology, Biostatistics & Occupational Health, McGill University, Montreal, Canada – name: 1 Centre for Clinical Epidemiology and Community Studies of the Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Canada – name: 5 Institute of Medical Biometry and Medical Informatics, University of Freiburg, Freiburg, Germany – name: 6 Division of Infectious Diseases, Jewish General Hospital, McGill University, Montreal, Canada |
| Author_xml | – sequence: 1 givenname: Carmine surname: Rossi fullname: Rossi, Carmine – sequence: 2 givenname: Ian surname: Shrier fullname: Shrier, Ian – sequence: 3 givenname: Lee surname: Marshall fullname: Marshall, Lee – sequence: 4 givenname: Sonya surname: Cnossen fullname: Cnossen, Sonya – sequence: 5 givenname: Kevin surname: Schwartzman fullname: Schwartzman, Kevin – sequence: 6 givenname: Marina B. surname: Klein fullname: Klein, Marina B. – sequence: 7 givenname: Guido surname: Schwarzer fullname: Schwarzer, Guido – sequence: 8 givenname: Chris surname: Greenaway fullname: Greenaway, Chris |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22957088$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNk99rFDEQxxep2B_6H4guCKIPd242ySbXB-Esag8qlVb7GrLJ7F3KbnIm2er9C_7VZnvX0itFSh4SJp_5zmQys5_tWGchy16iYowwQx8uXe-tbMfLZB4XBSEVQk-yPTTB5agqC7xz57yb7YdwWRQU86p6lu2W5YSygvO97O85eLf0cCVbsApy1-RHC--sUfkxLGU00YT8U35hfB_ymW1AReNsLq3Ov3vjfD7rut6auMqNHc5m7qWN4Ro4g6afA4TDfJqfr0KELumpZL4y8Pua-AZRjqbpFatgwvPsaSPbAC82-0H288vnH0fHo5PTr7Oj6clIsQmKI0xoXUnJK4yA1awsacNZw7TGdVFpphHVfAJQ8IZVUDOOuaaMKckaBYCYxAfZ67XusnVBbMoYBMJlRQkpU9EOstma0E5eiqU3nfQr4aQR1wbn50L69JQWBNK6QLyhNS0RYbrhEtW8JBXjUHFCq6T1cROtrzvQCmz0st0S3b6xZiHm7kpgggliKAm82wh496uHEEVngoK2lRZcn_IuJpgwhAh-BIo5nZSI0oS-uYc-XIgNNU_tIYxtXEpRDaJiSlPA1EJ4yHD8AJWWhs6o1J6NSfYth_dbDomJ8CfOZR-CmJ2fPZ49vdhm395hFyDbuAiu7YeWDdvgq7ufcvsbN3ORALIGlHcheGhuEVSIYfxuyiWG8ROb8Utuh_fclIlyCJ8qYtr_O_8D5k41UA |
| CitedBy_id | crossref_primary_10_3389_ijph_2021_602394 crossref_primary_10_7759_cureus_74243 crossref_primary_10_1093_jtm_taac136 crossref_primary_10_1186_s13031_019_0188_y crossref_primary_10_1016_j_dld_2019_05_023 crossref_primary_10_2807_1560_7917_ES_2018_23_10_17_00176 crossref_primary_10_4254_wjh_v7_i30_2955 crossref_primary_10_3390_ijerph19159157 crossref_primary_10_1128_JCM_02297_13 crossref_primary_10_1007_s00005_013_0219_0 crossref_primary_10_1186_s12879_021_05946_7 crossref_primary_10_1371_journal_pone_0189196 crossref_primary_10_1097_MD_0000000000001501 crossref_primary_10_1111_jgh_14984 crossref_primary_10_1186_s12889_018_6038_9 crossref_primary_10_1016_j_eimce_2024_04_010 crossref_primary_10_1111_jvh_13770 crossref_primary_10_1007_s10903_015_0294_x crossref_primary_10_1093_jtm_tay131 crossref_primary_10_1007_s10903_016_0486_z crossref_primary_10_3390_brainsci12020188 crossref_primary_10_1016_j_eimc_2020_05_027 crossref_primary_10_1016_j_eclinm_2018_10_006 crossref_primary_10_1016_j_healthpol_2020_12_010 crossref_primary_10_1007_s11901_021_00566_w crossref_primary_10_1177_00333549161310S216 crossref_primary_10_1186_1471_2334_13_181 crossref_primary_10_1007_s10096_017_3126_1 crossref_primary_10_1007_s10903_018_0705_x crossref_primary_10_1371_journal_pone_0078548 crossref_primary_10_1093_jtm_taab025 crossref_primary_10_1111_trf_12850 crossref_primary_10_1093_aje_kwx064 crossref_primary_10_1186_s12879_017_2778_x crossref_primary_10_1111_liv_12222 crossref_primary_10_1186_s12916_018_1034_6 crossref_primary_10_1186_s12879_023_08861_1 crossref_primary_10_1371_journal_pone_0316726 crossref_primary_10_17269_s41997_020_00435_x crossref_primary_10_1371_journal_pone_0184082 crossref_primary_10_3389_fpubh_2022_934050 crossref_primary_10_1093_jtm_taae094 crossref_primary_10_3390_v14051085 crossref_primary_10_1007_s00431_019_03405_9 crossref_primary_10_2105_AJPH_2016_303203 crossref_primary_10_1016_j_jiph_2018_10_004 crossref_primary_10_1016_S1473_3099_23_00590_X crossref_primary_10_1016_j_gaceta_2014_05_007 crossref_primary_10_1111_jvh_13727 crossref_primary_10_3389_fpubh_2023_1162705 crossref_primary_10_1007_s10903_020_01058_7 crossref_primary_10_1136_bmjopen_2022_067429 crossref_primary_10_1016_j_bpg_2017_05_008 crossref_primary_10_1200_OP_22_00074 crossref_primary_10_1093_jtm_taz007 crossref_primary_10_1016_j_idc_2018_10_014 crossref_primary_10_1111_aji_12667 crossref_primary_10_1080_21645515_2022_2054602 crossref_primary_10_1093_eurpub_ckv151 crossref_primary_10_1186_s40985_017_0065_4 crossref_primary_10_3748_wjg_v28_i35_5217 crossref_primary_10_1007_s10900_019_00668_z crossref_primary_10_1016_j_jhep_2015_04_026 crossref_primary_10_3748_wjg_v20_i33_11595 crossref_primary_10_1007_s11901_015_0269_3 crossref_primary_10_1016_j_revmed_2019_03_333 crossref_primary_10_1016_j_cld_2021_06_001 crossref_primary_10_1136_bmjopen_2023_075315 crossref_primary_10_1111_jvh_12248 crossref_primary_10_46310_tjim_899718 crossref_primary_10_1016_j_mcna_2015_05_006 crossref_primary_10_1111_jvh_12120 crossref_primary_10_1007_s10903_016_0543_7 crossref_primary_10_1080_20477724_2017_1281374 crossref_primary_10_3349_ymj_2018_59_9_1072 crossref_primary_10_1016_j_eimce_2020_05_018 crossref_primary_10_2471_BLT_20_260919 crossref_primary_10_1007_s10903_021_01305_5 crossref_primary_10_1111_jvh_13866 crossref_primary_10_22328_2077_9828_2024_16_3_94_106 crossref_primary_10_3390_ijerph18168534 crossref_primary_10_1007_s40615_018_0483_0 crossref_primary_10_1016_j_jhep_2015_06_026 crossref_primary_10_3390_ijerph19084642 crossref_primary_10_4269_ajtmh_19_0687 crossref_primary_10_1371_journal_pone_0088829 crossref_primary_10_3390_idr15020020 crossref_primary_10_36233_0507_4088_234 crossref_primary_10_1371_journal_pone_0136074 crossref_primary_10_5812_hepatmon_41781 crossref_primary_10_1093_eurpub_cky003 crossref_primary_10_1111_jtm_12120 crossref_primary_10_1186_s12889_015_1476_0 crossref_primary_10_2807_1560_7917_ES_2023_28_30_2200738 crossref_primary_10_1177_00333549141295S305 crossref_primary_10_3346_jkms_2023_38_e270 crossref_primary_10_1186_s12879_018_3041_9 crossref_primary_10_1002_jmv_25457 crossref_primary_10_52827_hititmedj_950527 crossref_primary_10_3390_ijerph15091898 crossref_primary_10_3390_v12030305 crossref_primary_10_1016_S0140_6736_14_60220_8 crossref_primary_10_1016_j_eimc_2024_04_005 crossref_primary_10_3399_bjgp16X684817 crossref_primary_10_1016_S2095_3119_14_60914_X |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2012 Public Library of Science Rossi et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2012 Rossi et al 2012 Rossi et al |
| Copyright_xml | – notice: COPYRIGHT 2012 Public Library of Science – notice: Rossi et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2012 Rossi et al 2012 Rossi et al |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM IOV ISR 3V. 7QG 7QL 7QO 7RV 7SN 7SS 7T5 7TG 7TM 7U9 7X2 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABJCF ABUWG AEUYN AFKRA ARAPS ATCPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU D1I DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB. KB0 KL. L6V LK8 M0K M0S M1P M7N M7P M7S NAPCQ P5Z P62 P64 PATMY PDBOC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PTHSS PYCSY RC3 7X8 5PM DOA |
| DOI | 10.1371/journal.pone.0044611 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Opposing Viewpoints Gale In Context: Science ProQuest Central (Corporate) Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts Nursing & Allied Health Database Ecology Abstracts Entomology Abstracts (Full archive) Immunology Abstracts Meteorological & Geoastrophysical Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Agricultural Science Collection Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Materials Science & Engineering Collection ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection Agricultural & Environmental Science Collection ProQuest Central Essentials Biological Science Collection ProQuest Central Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Materials Science Collection ProQuest Central Engineering Research Database ProQuest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts ProQuest SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Materials Science Database Nursing & Allied Health Database (Alumni Edition) Meteorological & Geoastrophysical Abstracts - Academic ProQuest Engineering Collection Biological Sciences Agriculture Science Database ProQuest Health & Medical Collection Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Engineering Database ProQuest Nursing & Allied Health Premium Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Environmental Science Database Materials Science Collection ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Engineering Collection Environmental Science Collection Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database Publicly Available Content Database ProQuest Central Student ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Meteorological & Geoastrophysical Abstracts Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Engineering Collection Advanced Technologies & Aerospace Collection Engineering Database Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Agricultural Science Collection ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Environmental Science Collection Entomology Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Meteorological & Geoastrophysical Abstracts - Academic ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) Materials Science Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts ProQuest Engineering Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts Materials Science Database ProQuest Materials Science Collection ProQuest Public Health ProQuest Nursing & Allied Health Source ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Animal Behavior Abstracts Materials Science & Engineering Collection Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE Agricultural Science Database MEDLINE - Academic AIDS and Cancer Research Abstracts |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Sciences (General) Geography Medicine Biology |
| DocumentTitleAlternate | Seroprevalence of Chronic Hepatitis B in Migrants |
| EISSN | 1932-6203 |
| ExternalDocumentID | 1326544219 oai_doaj_org_article_1dd018f5b52147df8a1b824678e68456 PMC3434171 2943644111 A543308831 22957088 10_1371_journal_pone_0044611 |
| Genre | Meta-Analysis Research Support, Non-U.S. Gov't Systematic Review Journal Article |
| GeographicLocations | Canada United States--US Montreal Quebec Canada |
| GeographicLocations_xml | – name: Canada – name: United States--US – name: Montreal Quebec Canada |
| GroupedDBID | --- 123 29O 2WC 53G 5VS 7RV 7X2 7X7 7XC 88E 8AO 8C1 8CJ 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ AAUCC AAWOE AAYXX ABDBF ABIVO ABJCF ABUWG ACGFO ACIHN ACIWK ACPRK ACUHS ADBBV ADRAZ AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS APEBS ARAPS ATCPS BAWUL BBNVY BCNDV BENPR BGLVJ BHPHI BKEYQ BPHCQ BVXVI BWKFM CCPQU CITATION CS3 D1I D1J D1K DIK DU5 E3Z EAP EAS EBD EMOBN ESX EX3 F5P FPL FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IAO IEA IGS IHR IHW INH INR IOV IPNFZ IPY ISE ISR ITC K6- KB. KQ8 L6V LK5 LK8 M0K M1P M48 M7P M7R M7S M~E NAPCQ O5R O5S OK1 OVT P2P P62 PATMY PDBOC PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO PTHSS PYCSY RIG RNS RPM SV3 TR2 UKHRP WOQ WOW ~02 ~KM CGR CUY CVF ECM EIF NPM PJZUB PPXIY PQGLB PV9 RZL BBORY PMFND 3V. 7QG 7QL 7QO 7SN 7SS 7T5 7TG 7TM 7U9 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ H94 K9. KL. M7N P64 PKEHL PQEST PQUKI PRINS RC3 7X8 5PM PUEGO AAPBV ABPTK N95 |
| ID | FETCH-LOGICAL-c791t-345b6aa8631e7b7225f87f7dd3b06d7d15d89ee08f76eb7838d577ca7fcee17a3 |
| IEDL.DBID | M48 |
| ISSN | 1932-6203 |
| IngestDate | Sun May 07 16:28:40 EDT 2023 Wed Aug 27 01:30:37 EDT 2025 Thu Aug 21 14:33:14 EDT 2025 Mon Jul 21 10:39:02 EDT 2025 Fri Jul 11 01:40:23 EDT 2025 Fri Jul 25 11:45:16 EDT 2025 Tue Jun 17 21:24:09 EDT 2025 Tue Jun 10 20:29:50 EDT 2025 Fri Jun 27 04:38:13 EDT 2025 Fri Jun 27 04:36:46 EDT 2025 Thu May 22 21:19:52 EDT 2025 Mon Jul 21 05:31:56 EDT 2025 Thu Apr 24 22:56:09 EDT 2025 Tue Jul 01 02:42:18 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 9 |
| Language | English |
| License | This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. Creative Commons Attribution License |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c791t-345b6aa8631e7b7225f87f7dd3b06d7d15d89ee08f76eb7838d577ca7fcee17a3 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Article-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 ObjectType-Undefined-4 ObjectType-Feature-1 Competing Interests: The authors have declared that no competing interests exist. Conceived and designed the experiments: CR CG. Performed the experiments: CR LM. Analyzed the data: CR CG GS IS. Wrote the paper: CR CG. Designed the software used in the analysis: GS. Participated in critical discussion of the draft initial findings and in revision of the manuscript: CG KS SC MK. |
| OpenAccessLink | https://www.proquest.com/docview/1326544219?pq-origsite=%requestingapplication% |
| PMID | 22957088 |
| PQID | 1326544219 |
| PQPubID | 1436336 |
| PageCount | e44611 |
| ParticipantIDs | plos_journals_1326544219 doaj_primary_oai_doaj_org_article_1dd018f5b52147df8a1b824678e68456 pubmedcentral_primary_oai_pubmedcentral_nih_gov_3434171 proquest_miscellaneous_1093471143 proquest_miscellaneous_1038592155 proquest_journals_1326544219 gale_infotracmisc_A543308831 gale_infotracacademiconefile_A543308831 gale_incontextgauss_ISR_A543308831 gale_incontextgauss_IOV_A543308831 gale_healthsolutions_A543308831 pubmed_primary_22957088 crossref_primary_10_1371_journal_pone_0044611 crossref_citationtrail_10_1371_journal_pone_0044611 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2012-09-05 |
| PublicationDateYYYYMMDD | 2012-09-05 |
| PublicationDate_xml | – month: 09 year: 2012 text: 2012-09-05 day: 05 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: San Francisco – name: San Francisco, USA |
| PublicationTitle | PloS one |
| PublicationTitleAlternate | PLoS One |
| PublicationYear | 2012 |
| Publisher | Public Library of Science Public Library of Science (PLoS) |
| Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
| SSID | ssj0053866 |
| Score | 2.426728 |
| SecondaryResourceType | review_article |
| Snippet | International migrants experience increased mortality from hepatocellular carcinoma compared to host populations, largely due to undetected chronic hepatitis B... Background International migrants experience increased mortality from hepatocellular carcinoma compared to host populations, largely due to undetected chronic... BackgroundInternational migrants experience increased mortality from hepatocellular carcinoma compared to host populations, largely due to undetected chronic... Background International migrants experience increased mortality from hepatocellular carcinoma compared to host populations, largely due to undetected chronic... |
| SourceID | plos doaj pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | e44611 |
| SubjectTerms | Africa South of the Sahara Antibodies Antigens Asia, Eastern Biology Carcinoma, Hepatocellular - epidemiology Carcinoma, Hepatocellular - virology Census Chronic infection Comparative analysis Control methods Cost analysis Data processing Disease control Disease prevention Earth Sciences Emigrants and Immigrants Epidemiology Europe, Eastern Geography Health aspects Health risk assessment Health risks Hepatitis Hepatitis B Hepatitis B virus Hepatitis B virus - metabolism Hepatitis B, Chronic - blood Hepatitis B, Chronic - complications Hepatitis B, Chronic - virology Hepatocellular carcinoma Heterogeneity Hospitals Humans Immigrants Immigration policy Immunity Infections Infectious diseases Liver cancer Liver Neoplasms - epidemiology Liver Neoplasms - virology Medical research Medicine Meta-analysis Migrants Mortality Noncitizens Occupational health Prevalence Prevention Refugees Regression Analysis Regression models Reviews Risk Risk factors Seroepidemiologic Studies Serology Studies surface antigens Systematic review Vaccination Viral infections Viruses |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELbQnrggyqsLBQxCAg5p1-s49nJrEVVBAiSgqLfIie1tpJKs8qjUv8CvZsZxQoMqyoHbKvMlm8zbyXiGkBeG54YtrY2EE7BAwXf4CtKCKFcLbrnJrM3wfcfHT8nRcfzhRJxcGvWFNWF9e-CecXvMmAVTTmQCJ-oYpzTL1BLMW9lEQfRH7wsxb1hM9T4YrDhJwkY5LtlekMvupirtrv-GydgkEPl-_aNXnm3OquaqlPPPyslLoejwNrkVcki639_7FrlhyztkK1hpQ1-FVtKv75Kf4ApwzAmoE9Jo5Wjed8OlpxZrqduioQf0vKi7hg51WSXVpaGbuqhqWvjtI-0FEPF3sa6xbsYD4Im6tbXNG6rp737QtN8L4xE_bKsjHbqe3CPHh---vT2KwvSFKJcr1kY8FlmitUo4szKTYPdOSSeN4dkiMdIwYdTK2oVyMgGBKq6MkDLX0kHcZVLz-2RWAr-3CXV2aeA6ieMgudhqlSmeQeyEtQ6OPnZzwgdRpHloTY4TMs5S_71NwhKl52yKAkyDAOckGs_a9K05rsEfoJRHLDbW9gdA3dKgbul16jYnT1FH0n6X6uge0n0Rcw4em8PfPPcIbK5RYvXOWndNk77__P0fQF-_TEAvA8hVwI5chx0T8EzYtGuC3JkgwUXkE_I2avTAlQZ4tATOxxCt4MxBy68mPxvJeFGsyCtt1QEGPymvIGEUf8OsOCQ_kJLPyYPecEbu4xh5CXc3J3JiUhPxTCllcer7n_MYUi_JHv4PeT4iNyEFXvqqQbFDZm3d2ceQZrbZE-9RfgHJ_Hxa priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3fb9MwELagvPCCGL8WGGAQEvCQra7j2OUFdYipRRqgjU19i5LY7iJNSUnSB_4F_mruHDcQNA3eqvpL6vp85zv7_B0hrzTPNZsYEworIEDBPXwFbkGYqzE3XGfGZLjfcfw5np9Fn5Zi6TfcGp9WubWJzlDrKsc98gOImmIRRaBg79ffQ6wahaervoTGTXILqcswpUsu-4ALdDmO_XU5LtmBl87-uirNvjvJZGywHDnW_t42j9aXVXOV4_l3_uQfC9LRXXLHe5J01ol-h9ww5T2y43W1oW88ofTb--QnGAQsdgKTCttoZannxKVzgxnVbdHQQ3pe1JuGLnx2VknTUtOvdVHVdOEukbQ_aFHi52JVY_aMA5wYu1kZ07yjM3ras0LT7sjBIY5Nm4Zb7pMH5Ozo47cP89DXYAhzOWVtyCORxWmqYs6MzCRov1XSSq15No611ExoNTVmrKyMQayKKy2kzFNpYfVlMuUPyaiE8d4l1JqJhvfElivwKUyqMsUzWEEh4sECyDYgfCuKJPcE5Vgn4zJxp24SApVuZBMUYOIFGJCwf2rdEXT8A3-IUu6xSK_tvqjqVeK1NWFaj5myIhNYxklblbIMOg0Lu4kVuJwBeY5zJOnuqvZGIpmJiHOw2xx-5qVDIMVGiTk8q3TTNMniy_l_gE5PBqDXHmQrGI489fcm4D8hddcAuTdAgqHIB827OKO3o9Ikv1UKntzO8qubX_TN-FLMyytNtQEMHixPwW0U12GmHFwgcMwD8qhTnH70sZi8hN4FRA5UaiCeYUtZXDgWdB6BAybZ4-u7_oTcBhd34rICxR4ZtfXGPAU3ss2eOVvxC1xfcyU priority: 102 providerName: ProQuest |
| Title | Seroprevalence of Chronic Hepatitis B Virus Infection and Prior Immunity in Immigrants and Refugees: A Systematic Review and Meta-Analysis |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/22957088 https://www.proquest.com/docview/1326544219 https://www.proquest.com/docview/1038592155 https://www.proquest.com/docview/1093471143 https://pubmed.ncbi.nlm.nih.gov/PMC3434171 https://doaj.org/article/1dd018f5b52147df8a1b824678e68456 http://dx.doi.org/10.1371/journal.pone.0044611 |
| Volume | 7 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjR1db9Mw0BrdA7wgNj5WGMUgJOAhVVMnsYuE0Dq1DKQNNBjqW5TEThupJCVJEX3hB_CruXOcjKAOeLGq-uwk9237fEfIU8kiaQ-VstzYhQUK7uELcAusSAyYYjJUKsT9jtMz7-TCeTdzZzukrtlqEFhsXdphPamLfNn__nXzGgT-la7awO16UH-VpaqvTyjxsu8u2CaOonrqNOcKIN2eZy7QXTUS0wMPRy4f6GIsl7ZKp_RvFHdntcyKbV7pn8GVv1mr6S1y07iZ9Kjiiz2yo9J9ct1UPF9s9smeEeqCPjeZp1_cJj9Bc2BVFOA-7KNZTKMqeS5dKAy9LpOCjum3JF8XtA7jSmmQSrrKkyynib5tUm6gE38n8LS0LDQAfN16rlTxkgb0Mn00ra7OaIgvqgyswCRJuUMuppNPxyeWKdZgRXxklxZz3NALAuExW_GQg5qIBY-5lCwceJJL25VipNRAxNwD-gsmpMt5FPAYzLTNA3aXdFIgwwGhsRpKmMeLmQDnQwUiFCwEUwtLI6yUHHcJq8niRyaTORbUWPr6eI7DiqbCso909Q1du8RqRq2qTB7_gB8jxRtYzMOt_8jyuW_E2relHNgidkMX6z3JWAR2CC8NHoDyBPimXfII-cWvLrU22sQ_ch3GgMMYPOaJhsBcHCkG-8yDdVH4b99__g-gj-ctoGcGKM4AHVFgLljAN2GOrxbkYQsSNErU6j5A7q6xUgCOhoB5B4wbjKw5fnv346YbJ8UAvlRla4DBE-gR-Jfu32BGDHwl8OC75F4lRA32a5HsEt4SrxZ52j1pstDp0pnDUBPcv3LOB-QGuMFDHTnoHpJOma_VQ3A1y7BHrvEZh1Yc29hO3_TI7nhy9uG8pzdvelq7YPtj8guICoSX |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdGeYAXxPhaYTCDQMBDtrpOYhcJoQ6YWrYOtC_1LUtiu0SaktKkQvsX-GP4G7lLnEDQNHjZW1T_4ri-833Y5ztCniseK9bX2vGMBw4K7uFLMAucWPa45irSOsL9jsm-Pzp2P0296Qr5Wd-FwbDKWiaWglplMe6Rb4HX5HuuCwvs3fybg1Wj8HS1LqFRscWuPv8OLlv-dvwB6Pui39_5ePR-5NiqAk4sBqxwuOtFfhhKnzMtIgH8bKQwQike9XwlFPOUHGjdk0b4MFDJpfKEiENhQJ8wEXLo9xq5Doq3hytKTBsHD2SH79vreVywLcsNm_Ms1ZvlySljLfVXVglodEFnfpblFxm6f8dr_qEAd26TW9ZypcOK1VbJik7vkFUrG3L6yiawfn2X_AABhMVVgImxjWaG2hy8dKQxgrtIcrpNT5LFMqdjGw2W0jBV9MsiyRZ0XF5aKc5pkuJzMltgtE4JONBmOdM6f0OH9LDJQk2rI44SMdFF6NS5Vu6R4yuhzn3SSWG-1wg1uq-gH99wCTaMDmUkeQQaGzwsLLhsuoTXpAhimxAd63KcBeUpnwDHqJrZAAkYWAJ2idO8Na8SgvwDv41UbrCYzrv8IVvMAisdAqZUj0njRR6WjVJGhiyCQYMhoX0JJm6XbCCPBNXd2EYoBUPP5Rz0BIfPPCsRmNIjxZihWbjM82D8-eQ_QIcHLdBLCzIZTEcc2nsa8J8wVVgLud5CgmCKW81ryNH1rOTB7yUMb9ZcfnHz06YZO8U4wFRnS8DgQfYAzFTvMsyAg8kFjkCXPKgWTjP7WLxewOi6RLSWVIs87ZY0-VpmXecuGHyCPbx86Bvkxuhoshfsjfd3H5GbYF73y4hEb510isVSPwYTtoielHKDktOrFlS_AKhJsNY |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLZGkRAviHFbYTCDQMBD1rquYxcJoY5RrYyNaTf1LSSxXSJNSWlaof0FfhK_jnMSJxA0DV72VtVfUtfnbh-fQ8hzzWPNesZ4wgoIUHAPX4Fb4MWqyw3XkTER7nfs7fs7J_2PEzFZIT-ruzCYVlnpxEJR6yzGPfIORE2-6PdBwDrWpUUcbI_ezb552EEKT1qrdholi-ya8-8QvuVvx9tA6xe93ujD8fsdz3UY8GI5YAuP90Xkh6HyOTMyksDbVkkrteZR19dSM6HVwJiustKHSSuutJAyDqUF28JkyOG918h1yQVDGZOTOtgDPeL77qoel6zjOGNzlqVmszhFZaxhCouOAbVdaM3Osvwip_fv3M0_jOHoNrnlvFg6LNlulayY9A5ZdXoip69cMevXd8kPUEbYaAUYGsdoZqmrx0t3DGZzL5KcbtHTZL7M6dhlhqU0TDU9mCfZnI6LCyyLc5qk-DmZzjFzpwAcGrucGpO_oUN6VFekpuVxR4HYM4vQq-qu3CMnV0Kd-6SVwnqvEWpNT8N7fMsV-DMmVJHiEVhviLaw-bJtE16RIohdcXTs0XEWFCd-EoKkcmUDJGDgCNgmXv3UrCwO8g_8FlK5xmJp7-KLbD4NnKYImNZdpqyIBLaQ0laFLIJJg1NhfAXubptsII8E5T3ZWkEFQ9HnHGwGh595ViCwvEeKgjINl3kejD-f_gfo6LABeulANoPliEN3ZwP-E5YNayDXG0hQUnFjeA05ulqVPPgtzvBkxeUXDz-th_GlmBOYmmwJGDzUHoDLKi7DDDi4XxAUtMmDUnDq1cdG9hJm1yayIVIN8jRH0uRrUYGd98H5k-zh5VPfIDdARQWfxvu7j8hN8LR7RXKiWCetxXxpHoM3u4ieFGqDki9Xrad-AfXmtQw |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Seroprevalence+of+chronic+hepatitis+B+virus+infection+and+prior+immunity+in+immigrants+and+refugees%3A+a+systematic+review+and+meta-analysis&rft.jtitle=PloS+one&rft.au=Rossi%2C+Carmine&rft.au=Shrier%2C+Ian&rft.au=Marshall%2C+Lee&rft.au=Cnossen%2C+Sonya&rft.date=2012-09-05&rft.eissn=1932-6203&rft.volume=7&rft.issue=9&rft.spage=e44611&rft_id=info:doi/10.1371%2Fjournal.pone.0044611&rft_id=info%3Apmid%2F22957088&rft.externalDocID=22957088 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon |